InvestorsHub Logo
Followers 3
Posts 1199
Boards Moderated 0
Alias Born 01/19/2010

Re: crammerfool post# 5048

Wednesday, 06/16/2010 1:01:32 PM

Wednesday, June 16, 2010 1:01:32 PM

Post# of 19508
Posted this morning. I thought I saw this news release (now shown in 3rd part) posted here yesterday, but when I look now I do not see it. Maybe it was on Yahoo, not sure any more, or the site here deleted it thinking it was not relavent.

======================================================================

This was taken from Positron's 8-K on May 11, 2010. Wondering how any of this may be affected or affects the partnership.

Affiliated entities of Positron include companies with common significant shareholders, joint venture companies, joint venture partners and companies with common management or control.
...Imagin Diagnostic Centres, Inc. (“IMAGIN”)
...Quantum Molecular Pharmaceuticals, Inc. (“QMP”)
...Imagin Molecular Corporation (“IMGM”)
...Solaris Opportunity Fund (“Solaris”)
...Neusoft Medical Systems Co. (“NMS”)
...Neusoft Positron Medical Systems Co., Ltd. (“NPMS”)
...Positron Acquisition Corporation (“PAC”)
...Imagin Nuclear Partners (“INP”)
...Note: PAC and INP are wholly-owned subsidiaries of IMGM.


======================================================================

Just more miscellaneous information taken from the 8-K on May 11, 2010.

Positron has the right management with the necessary expertise to meet our objectives. Positron's currently working with a number of strategic alliances that mutually benefit all parties in our expanding businesses.

Positron has an agreement with an industry-leading strategic partner. Positron has agreed with this partner that due to a recent expansion of the relationship and competitive advantages that it is in the best interest of all parties not to disclose any further details at this time. We'll do so in the very near future.

Based on market research and unique positioning in the marketplace, Positron’s targeted revenue projections are approximately $200 million over the next three years and an excess of $1 billion in the next five years. These sales numbers reflect Positron's PET devices and radiopharmaceutical sales and includes accelerated growth that will come from strategic partners.


======================================================================

The news was out first back on 5/21, and I am wondering why they just released the story again? The timing just seems all to odd to me - good or bad, I have no thoughts about it yet.

http://www.forbes.com/feeds/businesswire/2010/06/15/businesswire141113044.html

Press Release
Imagin Molecular Corporation to Change Its Name to the Planet Bottle Corporation
06.15.10, 09:44 AM EDT

BusinessWire - The shareholders of Imagin Molecular Corporation (IMGM) by consent of over 51% of the shareholders have approved a name change of the company to "The Planet Bottle Corporation" (PBC). The new name was chosen because it is expected that the fastest growing segments of the newly revitalized company are environmental projects especially the oxo-biodegradable PET plastic bottle of The Planet Green Bottle Corporation (PGBC). PGBC announced separately an exclusive agreement with Wells Plastics Ltd. of the UK (www.wellsplastics.com) wherein PGBC has introduced a proprietary, patent pending masterbatch additive which will cause the ordinary PET (polyethylene terephthalate) plastic bottle to oxo-biodegrade in 10 to 20 years versus estimates of up to 1,000 years for untreated, non-degradable PET plastic bottle. PGBC, a 51% owned subsidiary to the Planet Bottle Corporation received the registered trademark "The Planet Bottle".

Patrick J. Rooney, Director of Corporate Development for PGBC stated, "The Planet Bottle Corporation is in the business of developing and exploiting certain proprietary technologies which, if successful, could have a profound effect on the production and distribution of the multi-billions of PET (polyethylene terephthalate) plastic bottles that are discarded annually. Only 27% of plastic bottles are recycled with 73% going elsewhere. Planet Bottle has combined two concepts and created a singular solution unique to only Planet Bottle. R-PET describes PET plastic recycled and converted to many non-bottle products, such as t-shirts and carpets as well as recycled bottle to bottle production of a new PET plastic bottle. Until only recently R-PET for bottle to bottle recycling was too scarce and too expensive to be part of a solution. Planet Bottle has incorporated its proprietary REVERTE additive into the production process of R-PET to create the world's first "oxo-biodegradable R-PET plastic bottle". It's easy to sell a R-PET solution, after all COKE, Pepsi and Nestle have all endorsed the R-PET solution. REVERTE merely adds an "insurance policy" to the bottle to deal with the 73% of plastic bottles that are not recycled globally. Our plastic bottles will oxo-biodegrade in microbial environments. Microbes exist in almost all of the environments where bottles are discarded.

Yahoo! BuzzPlanet Bottle continues to introduce brand owners of beverage companies to its proprietary additive, Reverte(TM), as developed by Wells Plastics of the UK. The early adopters are incorporating Reverte in order to facilitate accelerated degradation of plastic. A new concept is being introduced by brand owners to display the Planet Bottle logo which sends the message in the bottle which denotes "This bottle is made from recycled plastic bottles and we recommend that you recycle it again. If the bottle gets inadvertently diverted to landfill or a ditch, it will oxo-biodegrade. The Planet Bottle believes it has an important solution to save the planet from plastic bottle pollution".

About Imagin Molecular Corporation:

Imagin Molecular Corporation (IMGM) is a company dedicated to socially responsible issues. IMGM main areas of interest are focused on medical and environmental. IMGM through its subsidiary Positron Cardiac CARE Clinics ("PCCC") is planning to open Cardiac Disease Reversal Clinics across Canada and after initial success across the USA and globally.

IMGM through a newly to-be-formed 51% owned subsidiary The Planet Green Bottle Corporation has developed and is introducing globally through a subsidiary, the world's first and only oxo-biodegradable PET (polyethylene terephthalate) plastic bottle. The Planet Green oxo-biodegradable technology was developed by Wells Plastics Ltd of the UK and is proprietary with patent pending trademarked by Wells as Reverte.

Imagin Molecular Corporation strategy and focus in its medical segment is dedicated to capitalizing on opportunities in positron emission tomography (PET) directed toward the diagnosis of cancer, heart disease and neurological diseases. PET is an advanced medical diagnostic imaging procedure used by physicians in the detection of certain cancers, coronary disease and neurological disorders including Alzheimer's disease. IMAGIN Molecular Corporation has a large strategic equity block position in Positron Corporation. The Positron technology is considered to be the gold standard for cardiac disease diagnosis.

About Planet Green Bottle Corporation

Planet Green Bottle Corporation ("PGBC") initiated with Wells Plastics Ltd. of the UK, the development of a masterbatch additive which causes a PET plastic bottle to become oxo-biodegradable in the environment. The Planet Green concept is to promote its "The PLANET BOTTLE" logo as a brand enhancer wherein the consumer will search for "The PLANET BOTTLE" logo on a brand owner's label as a sign that the plastic bottles and packaging are eco-friendly and will oxo-biodegrade over 10-20 years as opposed to perhaps over 1,000 years for non-treated PET plastic. Planet Green markets its product to brand owners globally. Planet Green is also working with governmental agencies around the world in order to influence legislation mandating that all plastics be treated with oxo-biodegradable additives as a step toward curtailing the pollution of the Planet with Plastic. IMGM acquired the proprietary position and intellectual property of PGBC of Canada in exchange for giving up a 49% interest in its corporate venture to be also called PGBC, a Delaware-incorporated subsidiary.

SOURCE: The Planet Bottle Corporation

For The Planet Bottle Corporation Patrick J. Rooney Director of Corporate Development 416 941-9955